- RecruitingPhase II
Sotagliflozin in patients with heart failure symptoms and type 1 diabetes
This UK trial looks at whether a daily tablet called sotagliflozin can help people living with both type 1 diabetes and heart failure. Researchers want to see if the medication improves everyday symptoms, boosts quality of life, and is safe to use alongside standard daily insulin routines.
For: Type 1 Diabetes, Heart FailureUnited Kingdom · England · Scotland - Not yet recruitingPHASE2
Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia
This study looks at a new drug, sotagliflozin, to see if it can protect kidneys in people with type 1 diabetes. Researchers want to understand how it affects kidney oxygen levels and overall kidney health over 12 weeks.
For: Nephropathy · Diabetic Nephropathies · Diabetes Mellitus, Type 1Denmark · United Kingdom - Active not recruitingPHASE3
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
This study is looking at a new medication, sotagliflozin, to see if it can help people with a heart condition called hypertrophic cardiomyopathy (HCM). It aims to find out if the drug improves symptoms and daily activities compared to a dummy pill.
For: Obstructive Cardiomyopathy, Hypertrophic · Non-obstructive Hypertrophic CardiomyopathyUnited States · Argentina · Belgium - RecruitingPHASE2
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
This study looks at whether a tablet called sotagliflozin can help people with type 1 diabetes and heart failure feel better. We're testing if it improves their quality of life and is safe, compared to a dummy pill.
For: Type 1 Diabetes · Heart FailureUnited Kingdom